Please upgrade to the latest version of Flash Player.

Click here if you already have Flash Player installed.

Please upgrade to the latest version of Flash Player.

Click here if you already have Flash Player installed.

Plastic Surgeon Dr. Michele Koo’s Blog | St. Louis | Kansas City Lifted Breasts

Archive for the ‘Lifted Breasts’ Category

What Questions Do you Ask Your Plastic Surgeon When Considering Breast Surgery??

Wednesday, July 28th, 2010

So, you’re thinking of having breast surgery…augmentation, reduction, lift, or perhaps implant exchange. What do you ask your plastic surgeon and how do you know she is qualified? Most importantly, how can you be sure she will take care of you and keep you are safe?

First, you want to make sure your plastic surgeon is Board Certified and a Member of the Aesthetic Society if you are considering any kind cosmetic procedure.

Second, do your research. Insist upon seeing photographs of your plastic surgeons previous patients and ask to speak with them regarding their experience. Check out your surgeon’s website. Does their philosophy and approach resonate with you?

Third, during your consultation, ask yourself if you feel comfortable with your surgeon. Do you trust her? Do you click with her? Do you like her? These impressions are imperative when choosing your surgeon, because your relationship is just as important as the results with which she will provide you. This bond will not only make you feel safer but also provide your doctor with the insight to give you exactly what you want.

Last, ask your friends who they’ve seen. Were they happy with their results? Would they go back? This will help you make an informed decision.

Good luck with your search!!

What’s Involved in a Mommy Makeover & When Can You Have One After Delivery?

Thursday, May 13th, 2010

So you’ve had a few kids and now you’re 20-40 lbs heavier with breasts that are deflated, stretch marks all over your tummy, belly button & breasts. You have skin that hangs over your pubic area that prevent you from being able to tuck in any shirt or find clothes that fit nicely.

You try to eat well, exercise, and be healthy but all you see are your flat saggy breasts and hanging tummy skin. You get discouraged and depressed and you eat that extra piece of cheesecake because … what’s the use, nothing makes any difference!

Let me tell you, break the vicious cycle and take charge of your life. It is true, you will not be able to make the skin shrink or lift your breasts with diet and exercise but it will make you mentally feel better until you can get a MOMMY MAKEOVER!!

What is a MOMMY MAKEOVER? It can consist of a breast augmentation with a breast lift, tummy tuck with liposuction, and/or brachioplasty to reduce the skin of the arms. You can have all of these surgeries done at one time with one recovery depending on how much excess skin and fat will be taken off.

(more…)

Why Breast Reductions and Breast Lifts Can Change Your Life Go from Granny to Playboy!

Monday, December 14th, 2009

Did you know that breast reductions are normally covered by your insurance plan and is one of the best things you will ever do for yourself. You will lift your breasts and stop that awful skin on skin sweating which results from your breasts touching your abdominal skin.

My favorite quote from one of my patients that comes to mind describing the results: “I just went from National Geographic to Playboy.”

That truly is how you will feel way better than nature.

The heavy pulling weight on your shoulders and neck will be relieved with the reduction in size of your breasts. DR KOO guides you as to the size you will be reduced to which will still be proportionate to body but so much lighter and perkier.

Even your tension headaches from the pull of your heavy breasts will be relieved. You will be able to exercise and be much more active helping you lose weight and feel and look even better.

Dr Koo’s office will work with you to make everything very easy and do all the paper work for you. Her office works with patients from all over the United States and especially college students coming home for the summer and the holidays who have limited time to have the surgery and to do all the paper work.

The BREAST REDUCTION is very safe and DR MICHELE KOO is a Board Certified Plastic Surgeon with extensive experience in the surgery and will make sure that everything goes very safely and smoothly for you. She understands what a woman wants her breasts to look like. She will lift your breasts and reshape and resize them to make you feel so much more comfortable.

Most women retain their nipple sensation and are still able to go on to breast feed after a breast reduction surgery. The relief and change in self esteem is profound. This is especially true for the young adult woman or even teenage who are mercilessly teased about their big breasts.

The surgery is not painful with a quick recovery and can most often be performed as an outpatient.

What to do with old hard breast implants? Are you embarassed?

Tuesday, December 8th, 2009

MOMMY MAKEOVER - A Sexy Body After Children IS Possible - Liposuction, Tummy Tuck, and Breast Lift and Augmentation

Monday, June 22nd, 2009

If you are sick and tired of being trapped by your saggy, lifeless, flat breasts and hanging skin with stretch marks after pregnancy and breast feeding there is something you can do about it.

Plastic surgery to remove all that excess skin and fat and lift your breasts to their original position with fullness on top can be achieved safely.

If you are looking for a MOMMY MAKEOVER, you have found the right person in Dr Michele Koo, MD, FACS, St Louis, MO, who is a Board Certified Plastic Surgeon. She will listen to exactly what you want and be able to get rid of that frustrating hanging large belly that has made you depressed for years with liposuction and a tummy tuck (abdominoplasty). At the same time you can address your breasts which may have lost most of the nice sexy full volume and is now hanging on your abdomen. She will examine you and determine if you need a breast lift alone or a breast lift along with a breast implant (breast augmentation) to achieve that full, firm, sexy and lifted breast that you used to have.

MOMMY MAKEOVERS addressing the breasts and tummy in one operation is very safe and Dr Koo will let you know how much can be done at one time safely, and whether you can achieve what you are looking for with only a breast augmentation and liposuction or if you need more contouring by removing skin with a breast lift and tummy tuck.

One of the most important aspects in the success of any surgical procedure is the physical condition of the patient at the time of surgery. Even though liposuction, breast augmentation and a tummy tuck are elective procedures, Dr Koo assesses you using the same standards as those used for anyone who is undergoing any type of surgery. This is very important for your safety and well being. Dr Koo emphasizes your safety above all and ensures that you will have an excellent outcome safely.

Dr Koo specializes in contouring the body after pregnancy and weight loss. She obtains a thorough medical history from all patients who are to undergo a MOMMY MAKEOVER and a diligent physical examination is performed. Surgical history, including previous procedures is obtained for the YOUR safety.

Patients with comorbid conditions such as tobacco use, hypertension, coronary artery disease, chronic obstructive pulmonary disease, diabetes mellitus, hepatitis C, and human immunodeficiency virus are screened carefully. Patients with a history of pulmonary embolism, deep vein thrombosis, or blood clotting disorders require added precautions, such as chemoprophylaxis and sequential compression devices.

Dr Koo uses sequential compression devices in the majority of liposuction, tummy tuck, and breast lift and breast augmentation procedures. Conditions that may increase the risk for deep venous thrombosis include chronic venous insufficiency, family history of thrombotic syndromes, obesity, trauma, severe infection, polycythemia, central nervous system disease, malignancy, homocystinemia, a history of pelvic or lower extremity radiation therapy, and use of birth control pills or hormone replacement therapy.

Medications that the patient may be taking is reviewed, as many common prescribed and over-the-counter medications may affect wound healing and blood clotting. Medications such as aspirin, nonsteroidal antiinflammatory agents, birth control pills, vitamin E, and herbal preparations such as St. John’s wort are recognized to interfere with the coagulation mechanism. Dr Koo recommends avoidance of such agents before surgery. Some medications may also interact with medications used during surgery.

MOMMY MAKEOVER BLOG continues on next Blog

BREAST IMPLANTS - BEAUTIFUL BREASTS - DR MICHELE KOO, MD, PLASTIC SURGEON, ST LOUIS - ILLINOIS, MISSOURI

Saturday, March 7th, 2009
BEFORE BREAST AUGMENTATION 34A

BEFORE BREAST AUGMENTATION 34A

AFTER BREAST AUGMENTATION 34D

AFTER BREAST AUGMENTATION 34D

DR.  MICHELE KOO, MD, FACS MISSOURI, ILLINOIS, KANSAS, 314-984-8331

Dr Michele Koo is a Board Certified Plastic Surgeon and a member of the Aesthetic Society, 314-984-8331, ST LOUIS, MISSOURI.
Dr Koo will give you specialized individualized attention for your special requests for your breast augmentation. She and her staff are tuned into serving your needs and wants and will give you customized individual service. Dr Koo’s philosophy is to make you happy and to serve you.

Dr Koo feels that there are certain facts that you should know about breast augmentation and breast implants and she wants you to be well informed. The better informed you are, the better your results will be as she will be able to communicate with you as to what your possibilities are. Her time is your time and she wants your surgery to be as perfect as it can be and that the size, shape, and look of your breasts will be exactly what you picture in your mind.

The following is an article in the Plastic and Reconstructive Journal that Dr Koo wants you to have access to by Dr William Adams of University of Texas Southwestern Medical University, December 2008. Dr Koo has her own techniques that are variants what is mentioned in the article but wants you to understand the preparation and techniques that go into determining your ultimate choice of implants, size, position, shape, and look of your breasts.

A process is defined as a group of practices that are completed successively to reach a goal. For 45 years, breast augmentation has been thought of as an isolated surgical procedure; however, well-documented elevated reoperation rates of 15 to 24 percent over 6 years in successive premarket approval studies have resulted in a critical analysis of this procedure. Factors that impact outcomes have been identified and practice recommendations have been established.

Background: Breast augmentation has been an integral part of plastic surgeons’ practices for over 40 years. Although devices have evolved, patient outcomes are still not ideal, as documented in multiple premarket approval clinical trials. Unlike many other areas of surgery, the practice of breast augmentation has suffered from the lack of a defined process for patient management. The purpose of this study was to clinically define and evaluate the process of breast augmentation and analyze patient outcomes using these practices compared with existing premarket approval trial data.

Methods: Three hundred consecutive primary breast augmentations from 2001 to 2005 were followed prospectively. Each patient underwent a defined process of breast augmentation including structured patient education and informed consent; tissue-based preoperative planning consultation; refined surgical technique; and structured postoperative instructions, management, and follow-up.

Results: The mean follow-up was 2.1 years. The most common complications were rippling and palpability, soft-tissue stretch, and hypersensitivity. The overall reoperation rate was 3.7 percent for the entire group and 4.7 percent and 2.9 percent for saline and form-stable cohesive gel implants, respectively.

Conclusions: Optimizing patient outcomes in breast augmentation requires defining the overall process to allow for enhanced patient outcomes. This is the first report that defines and integrates the entire process comprehensively that is validated by outcomes data. This process is transferable to other surgeons and, using this algorithm, patient outcomes in this study were superior to premarket approval clinical trial data. In summary, approaching this procedure with a global process produces superior patient outcomes in breast augmentation.

This analysis has resulted in a redefinition of this procedure to a much broader process beyond the actual surgical placement of the implant. Essential components include comprehensive patient education that enhances informed consent, tissue-based preoperative planning, refined surgical technique and rapid recovery, and a strictly defined postoperative management plan. Previous reports have defined individual key areas, and these principles have been integrated, refined, and customized into a comprehensive process that encompasses every key surgeon-staff-patient action point. Although each component may exist individually, the combination of these steps in succession has resulted in enhanced outcomes for patients far better than any one component practiced in isolation. In recent years, as key components of this process have been elucidated, it has been demonstrated that the process is transferable and reproducible. The purpose of this study was to clinically define and evaluate the process of breast augmentation and to prospectively analyze patient outcomes using these practices compared with existing premarket approval trial data.

All patients were treated by a single surgeon’s practice. Patients were followed prospectively from 2001 to 2006. A subgroup of the patients were followed in a U.S. Food and Drug Administration-approved clinical trial with clinical research organization oversight. The four primary subprocesses used for patient care were structured patient education, tissue-based clinical analysis, refined surgical technique, and defined postoperative regimen.

All patients underwent a patient education and informed consent process using a multimodality approach. Initial contact included verbal information and a web-based introduction to the practice philosophy of breast augmentation. Once the decision for consultation was made, a specific patient education consultation was performed to answer specific issues about breast augmentation. After 2002, a specific set of breast augmentation education and informed consent documents was customized based on previous publications in this Journal. Patients were required to complete the documents before their education consultation that was performed either over the phone or in person, lasting on average 45 to 60 minutes, and performed by a patient education specialist. During the education consultation, all concepts, issues, and limitations were addressed directly and covered with the patient, ultimately having the patient assume responsibility for the final decisions.

The surgeon consultation was performed only after successful completion of the education consultation. The average surgeon consultation time was 30 minutes. The two primary goals of the surgeon consultation were to objectively evaluate the patient’s breast and to ensure that the patient’s goals (previously defined in writing during the education consultation) were reasonable based on their breast dimensions and tissue. The tissue-based evaluation was based on previously published techniques. The basics of the High Five process allow the surgeon to preoperatively make the five critical decisions that determine outcomes for a breast augmentation:

1. Pocket plane.

2. Implant size (based on predicted tissue-based optimal fill volume of the breast).

3. Implant type.

4. Inframammary fold position.

5. Incision.

The implant size and type were based on two key factors: breast width and breast type (skin envelope compliance and preoperative fill). The rationale for selecting the individualized implant was reviewed with the patient and anyone else participating in the decision-making process.

The patient’s breast photographs were also reviewed with the patient and a photograph-analysis sheet was completed and initialed by the patient. Patient asymmetries were identified (size and shape) and discussed, and the reality that the postoperative breast will not match, realistic expectations for cleavage based on current intermammary distance, rationale for recommended pocket plane, and likelihood of implant palpability, particularly in the inferior and lateral parts of the breast, were all addressed directly with the patient by the surgeon while viewing the photographs.

The surgical plan was developed preoperatively following the surgeon consultation. All operations were performed under general anesthesia with short-acting full muscle paralysis, and patients were premedicated with a single dose of 400 mg of Celebrex (Pfizer, New York, N.Y.). The new inframammary fold incision was planned and executed as previously described. Implant pockets were created under direct vision with no blunt dissection using techniques to minimize tissue trauma. The same surgical principles were applied to all implant types, including smooth, round, and textured anatomical implants. Pocket preparation included the use of triple antibiotic irrigation and other techniques to minimize contamination of the implant, including glove change and wiping the skin before implant placement. Sizers were not found to be necessary in [297 of 300 (99 percent)] of cases, and the implant selection was determined during the preoperative consultation before the operative day. Incision closure was performed in three layers using a deep absorbable suture (3-0 Vicryl; Ethicon, Inc., Somerville, N.J.) for closure of the superficial fascia of the breast, a deep subdermal suture (4-0 polydioxanone), and subcuticular skin closure (4-0 Monocryl; Ethicon).

All patients were given detailed defined postoperative instructions. These were reinforced before the day of surgery and on the day of surgery, and verification of compliance was completed after the patient returned home. Patient outcomes, complications, and recovery were assessed and analyzed.

A total of 300 primary augmentation patients were followed prospectively between 2001 and 2006. Two subcohorts were also analyzed: (1) 128 consecutive patients undergoing saline primary breast augmentation from 2001 to 2006; and (2) 172 consecutive patients undergoing primary breast augmentation in U.S. Food and Drug Administration premarket approval clinical trials from 2002 to 2006 with standard clinical research oversight monitoring.

Patient demographics are listed. The mean age for the main cohort and subcohorts was 36 years. The average implant size was 289 cc for the entire cohort and 302 cc and 276 cc for the saline and form-stable cohesive gel subcohorts, respectively.

Details regarding the implant type and pocket plane are listed. The majority of all implants were in the dual-plane pocket. Ninety-eight percent of implants were placed by means of the inframammary fold incision.
Follow-up, patient outcomes and reoperations, and complications are listed. The mean follow-up was 2.1 years (range, 9 months to 6 years) for the entire cohort. Mean follow-up for saline and form-stable cohesive gel implants was 1.7 years (range, 9 months to 6 years) and 2.3 years (range, 1 to 5 years), respectively. The reoperation rates were 3.7 percent for the entire cohort and 4.7 percent and 2.9 percent, respectively, for the saline and form-stable gel implant subcohorts. The reasons for reoperation are listed. Ninety-seven percent of patients were able to return to normal activities of daily living (e.g., raise arms above head, drive car, wash, shop, eat, and dry hair) within 24 hours.

The belief that breast augmentation is a simple procedure encompassing little more than placing an implant in a pocket is a misconception, and advances in this procedure have been significant over the past 10 years; however, controlled clinical trials have demonstrated that reoperations continue to be significant (15 to 24 percent at 3 years) for this elective procedure. This procedure is much more complex than typically perceived, and the concept of the process of breast augmentation emphasizes the equal if not larger importance of the nonsurgical part of the process (e.g., education, tissue-based planning, and postoperative care compared with the surgical procedure itself).

The educational component cannot be overemphasized, as this remains the most critical yet often neglected part of the process. The key components of the educational subprocess are (1) to educate the patient on the practice philosophy and have the patient assume mutual responsibility that the implant will be selected based on her chosen preferences and in accordance with her breast dimensions and tissue or alternative methods recognizing the tradeoffs; and (2) by means of direct doctor-patient interaction to review the patient’s own photographs and point out key aspects that should be addressed preoperatively, including 100 percent asymmetry in all patients and limitation in correcting these asymmetries, reasons for implant palpability, and the likelihood of inferior and lateral pole deformity. The image analysis sheet is an extremely powerful yet simple tool that is part of the educational process and the surgeon planning consultation.

The tissue-based preoperative planning allows the surgeon to get on base and prevents the patient from striking out on her first try. The High Five process is one of two published and peer-reviewed tissue-based systems in the literature and provides the simplest way to determine optimal fill volume for any given breast.  Patients often come to the office wanting to look like a certain centerfold or bathing suit model or be a certain bra cup size, but through the educational process and tissue-based planning it is made very clear that it is about their tissues. Interestingly, the High Five process allows the surgeon to adjust the volume based on patient request, and in a separate publication, this author has found a significant increase of complications when volume is added above the High Five-recommended volume, particularly in high-risk patients [narrow (breast width <11.5), tight envelope (skin stretch <2)].

Also cogent is the artist versus the engineer issue, and who should pick the breast implant size: the patient or the doctor. No doubt, much of plastic surgery is both art and science; however, art in itself is truly unstructured and without definable boundaries. The thought that instituting a process-oriented approach will obstruct the skills of the artist is a misconception. Realistically, the process will only serve to enhance one’s artistic qualities, as it defines the limits that the artistic only approach cannot clearly elucidate.

Formerly, the surgical technique was often the only part of a breast augmentation that many surgeons considered. Surgical advances have currently not only enhanced the actual surgical procedure but clearly defined the importance of the educational and tissue-based planning portions of the process, as these allow the surgeon to make nearly every decision before entering the operating room. This not only allows the surgeon to make better decisions than have historically been made in the operating room (particularly implant size) but also allows the surgical procedure to proceed as efficiently as possible. The concept of a very precise, atraumatic dissection with prospective hemostasis (identifying and controlling vessels and perforators under direct vision before they bleed) allows for both breast pockets to be typically dissected in a total time of typically less that 10 minutes. This not only immensely reduces the amount of tissue trauma but reduces intraoperative narcotics, additional paralytics, and the need for reversing agents, all of which slow postoperative recovery. Although the use of appropriate breast pocket irrigation has been widely accepted, surgeons often ignore other potential points of periprosthetic contamination, including handling implants without clean gloves and contact of the implant with the outside of the thermoform container or other surgical site components. These practices do not fit with this refined surgical process and should be avoided to minimize complications, including capsular contracture and reoperation.

The last benefit of this refined surgical process is recovery, the second best indicator of the quality of the procedure delivered (with reoperation rate being the first). This report and others have documented full return to normal activities within 24 hours using this process. In this series, 97 percent of patients (291 of 300) returned to full normal activities of daily living, including washing and drying hair, getting dressed, picking up children younger than 3 years, driving a car, and other similar activities. All aerobic activities that increase heart above 100 beats per minute were restricted for 2 weeks.

Surgeons, patients, and medical personnel are often skeptical about the feasibility of 24-hour, fast track recovery. The process is often modified but, as discussed earlier, a process only functions if it is completed in proper order and procedure. Other adjuncts to the process such as injectables, drains, pain pumps, straps, special bras, narcotics, and limitation of arm movements all detract from the goal of speeding recovery.

On reviewing the data of this study, it is interesting that the reoperation rates were low for all cohorts compared with all premarket approval studies. Also, the lowest reoperation rates were reported for the most stringent studies, with clinical research oversight. The issue of size exchange has also been of interest. There were no patients who underwent reoperation in either cohort for size exchange. It has been suggested that the rate of actual size exchange is dependent on the tendency of the surgeon to respond to a patient’s request for size change. This opinion does not take into account the theme of this article on the true power of the process of breast augmentation. Size exchange requests within the first 2 postoperative years that result in reoperations for size or style exchange indicate a failure of the surgeon and staff with the patient education and tissue-based planning parts of the process. A patient who has decided to select her implant based on her individual optimal fill volume and what will be safest for her tissues understands the limitations, and these patients remain well educated postoperatively and generally do not request size exchange procedures. This does not mean that these patients do not go through the normal human psychological acclimatization of getting accustomed to their new breast size and forgetting how they were preoperatively, which is normal human nature, and approximately 20 percent of patients may make a comment to our staff regarding size postoperatively, but they are reminded of the reasons why the size implant was chosen and shown their side-by-side preoperative and postoperative photographs, which usually results in them reaffirming their initial decision (documented in writing) about implant size selection.

Although not the focus in this article, other differences in these data are consistent with other reports, with a trend for less capsular contracture in the form-stable gel implants and more soft-tissue stretch in saline implants. There was more rippling and palpability in the form-stable implants compared with the saline implants in this study and there was more rippling and palpability in the Contour Profile Gel implant than in the 410, which is consistent with other reports and likely attributable to the increased form stability of the 410. Retrospectively, this is not visible rippling but implant edge palpability, generally an innocuous finding that resulted in no further surgical revision, and future studies on form-stable implants should separate these criteria to avoid confusion. The diagnosis in this study was made only if the patient complained about palpability. Nevertheless, excellent overall outcomes were obtained with all implant types using this process-oriented approach.

Also cogent is that surgeons and manufacturers often like to talk in terms of results with specific implants; however, in the end, it is not about the implant but rather the process, as this is the most significant benefit to patients. Advances in implants in the future will enhance the process but never replace it. The process determines the patient experience, reoperation rate, and recovery, and the overall quality of the process delivered is directly proportional to the overall success.

Perhaps the most significant factor is that the process is transferable. This author was inspired by his mentor, John Tebbetts, to take basic principles and refine, customize, and develop them for clinical practice and surgeon education. By means of focused education and a defined curriculum, surgeons can acquire the skill, knowledge, and expertise to deliver the process described in this study. Independent surgeons in different stages of their careers have reported using similar concepts to produce similar patient outcomes. The combination of these reports totals over 2500 primary breast augmentations, with a mean follow-up of 6 years and a reoperation rate of less than 3 percent. The transferability of this process has also been demonstrated routinely in our residency program at the University of Texas Southwestern. Interested residents have been introduced individually to this process and taken through the phases with direct supervision. It is clear with their own developing practices that they are using these concepts to obtain excellent outcomes in patients.

Limitations of this study and comparison include the fact that any comparison between a selected surgeon(s) versus a large premarket approval clinical trial is not totally an apples to apples comparison, although the premarket approval trial surgeons are hand picked by the manufacturer based on known expertise with the procedure. Because of stringent follow-up of U.S. Food and Drug Administration clinical trials with clinical research oversight, reoperation rates might be expected to be higher, yet a 5- to 7-fold increase is not explained by this minor factor.

Interestingly, the data in this study would suggest that, in this series, the subcohort of only U.S. Food and Drug Administration premarket approval clinical trial patients is easily comparable and slightly better than the non-premarket approval data. There have also been reports of premarket approval clinical trial series using similar concepts demonstrating a 0 percent reoperation rate at 3 years.

There has also been speculation that the U.S. Food and Drug Administration requirement for reporting of reoperations that included non-device-related issues, such as breast biopsy, falsely elevates the reoperation rates. When correcting for non-device-related reoperations (breast biopsy and excisional biopsy), the reoperation rates at 3 years in the core gel studies for the two companies were 14 and 16.5 percent, which would still indicate a 4- to 5-fold decrease in reoperation rates using the process detailed in this study. The reoperation rate in this study was 3.7 percent compared with 15 to 24 percent for the all premarket approval studies performed in the past 10 years. Reoperations remain our most objective measure of how well we are doing with this procedure. The 2-year reoperation rate is most critical because the majority of the reoperations during this period are the ones that are related directly to the surgeon’s decisions and technique.

Isolated processes in breast augmentation have been reported to improve outcomes; however, this is the first single-series study to integrate and report a comprehensive methodology to positively impact patient outcomes. Similar to the use of defined processes in successful businesses and industry, implementing a defined process in breast augmentation serves to systematize this procedure and ultimately helps reduce outcomes resulting in reoperation. The economic impact of the process of breast augmentation for patients and surgical practices, although not the focus of this study, is profound not only immediately but over time, as the trend positively impacts the global breast augmentation market. In the end, the biggest winner in the process of breast augmentation is the patient… as it should be.

Dr Michele Koo, MD, FACS hopes this is article is helpful. She and her staff work tirelessly to achieve the perfect result for you and to make breast augmentation a good experience for you that will enhance your life, self image and self confidence. Dr Koo is emphatic about communicating with you regarding your breast size, shape, and suitability for your lifestyle, body type, and cosmetic results. Dr Koo will work with you until she achieves those results. 

 

IMPLANT EXCHANGE - HARD UNCOMFORTABLE BREAST IMPLANTS

Friday, February 27th, 2009
BEFORE IMPLANT EXCHANGE AND BREAST LIFTAFTER IMPLANT EXCHANGE AND BREAST LIFT

Dr Michele Koo, MD, Board Certified Plastic Surgeon, St Louis, Missouri, 314-984-8331.

Breast augmentation is an extremely popular and safe surgical procedure that 100’s of thousands of woman have undergone without any complications. The majority of these woman are extremely happy and would choose to have to surgery again if given the choice to do over again. In 2007, the FDA again allowed the use of silicone gel implants for elective breast augmentation for cosmetic reasons.

However, with time and aging of the implant, the breasts may change and the implant become encapsulated (scar formation around the implant). The breasts may become hard and misshapened and painful. The breasts may become too saggy and heavy and extremely uncomfortable for the woman.

Breast implant removal and replacement along with a breast lift is very safe and often a normal sequelae to breast augmentation that is over 15-20 years old. The recommended life of a saline or silicone implant is approximately 15-20 years. Whether a breasts starts to show the changes of encapsulation (hardening) and pain depends on where the original breast implants were placed, the original type of implant, and, of course, the patient herself.

The surgery that needs to be performed to change the breast implants is largely dependent on what was done at the time of the original surgery, whether the implant was placed under the breast or under the muscle, what type of implant was used, and what the breasts look and feel like in its current condition.

A breast implant exchange or a complete breast implant removal without an implant replacement can be performed. If the breasts have become saggy and have fallen so that they are too low on the chest, a breast lift may have to be performed at the same time as the breast implant replacement or removal. All of the above procedures can be performed very safely in one procedure by DR MICHELE KOO, MD of St Louis, MISSOURI, 314-984-8331.

There are a few points that Dr Koo wants you to understand about breast implants and breast augmentation according to an article by John B Tebbets in the Journal of Plastic and Reconstructive Surgery.

Factors That Affect Responses to a Breast Implant

Every medical device implanted into the human body is placed in an environment where certain factors cannot be predicted or controlled by the surgeon or the patient, especially factors related to a patient’s individual wound-healing characteristics and the genetic characteristics of each individual patient’s tissues.

A breast implant has a range of effects when placed into the body, effects that continue for the entire time the device is implanted. Short- and long-term effects of a breast implant in the body depend on three different sets of factors: device-related factors, surgery-related factors, and factors related to the patient’s wound-healing and genetic tissue characteristics. Surgeons and patients have some level of control over device-related and surgery-related factors, including implant type and size, maximal soft-tissue coverage over the implant, and optimal surgical techniques to minimize tissue trauma and bleeding. Neither surgeons nor patients, however, can predict or control patient wound-healing and genetic tissue characteristics.

Factors That No Surgeon or Patient Can Predict or Control

No surgeon or patient can predict or control a patient’s wound-healing characteristics or a patient’s genetic tissue characteristics, factors that can affect outcomes following breast augmentation. Each patient has unique, individual wound-healing and genetic tissue characteristics that influence the interaction between a breast implant and the surrounding tissues. Individual wound-healing characteristics influence the characteristics of the capsule or lining that forms around every breast implant and affect the degree to which that capsule tightens or contracts, which in turn determines whether capsular contracture will cause excessive firmness of the breast or other deformities. A patient’s wound-healing characteristics may also affect the quality of incision scars, the risks of infection or fluid production around an implant, and other factors that can affect the aesthetic result. Genetic and hormonal effects of pregnancy and nursing vary from patient to patient and can affect aesthetic results and outcomes.

A patient’s genetically determined tissue characteristics can affect the response of the patient’s tissue to the implant, including how much the skin will stretch and thin in response to a specific size implant and how the breast tissue overlying the implant will respond. Surgeons and patients can avoid selecting excessively large implants, but even an appropriate-size implant for a patient’s visible tissue characteristics may cause excessive stretch of the breast skin envelope in patients whose tissues do not adequately support the weight. Unfortunately, surgeons have no tests available to predict a patient’s wound-healing or tissue responses to a breast implant. As a result, no surgeon can predict or control the occurrence or severity of capsular contracture, infection, tissue stretch deformities, or other conditions relating to patient wound-healing and tissue characteristics.

Reoperations: The Risks, the Tradeoffs, and the Logic

Every additional reoperation that is required following placement of breast implants imposes additional risks, costs, and tradeoffs to the patient. Some reoperations are medically necessary, but others are not. Severe capsular contracture, infection, and fluid accumulation around an implant are medical reasons to perform an additional operation. A patient’s request for a size change to a larger or smaller implant, though desirable to the patient, is not medically necessary and imposes risks and costs that may not be logical medically. For example, although the risk of infection with implant exchange is small, it is not zero, and for the patient who experiences such a complication, the incidence is 100 percent and may require implant removal without replacement or may produce an uncorrectable deformity.

Every reoperation causes additional surgical trauma and bleeding, and healing after each additional surgery produces more scar tissue, the effects of which are uncontrollable. Seemingly simple operations such as a minor revision for implant malposition or excessive stretch, though usually safe, invoke healing mechanisms that are uncontrollable and can result in exchanging one deformity for another. Logically, reoperations should not be performed for reasons that have no medical necessity or to address relatively mild aesthetic conditions where the risks and effects of the surgery might possibly produce a change that is worse or different compared with the existing condition.

Implant Removal without Replacement: The Logic

Breast implants are not medically necessary devices. Regardless of the efforts and costs to place breast implants, if certain conditions or complications occur, continuing to attempt to salvage the implants or leaving implants in place can cause permanent damage to a patient’s tissues, producing deformities that are uncorrectable.

Once a patient has breast implants, virtually every surgeon and patient wants to keep the implants in place. The positive effects of implants make some patients unwilling to even consider removal without replacement under any circumstances. Removal without replacement must be a joint decision of the patient and surgeon, both of whom must recognize and acknowledge that the aesthetic consequences of removing implants may be far more preferable to possible permanent, uncorrectable deformities and additional reoperations with additional costs and risks if the implants are left in place. Surgeons and patients should define criteria for removal without replacement before the patient has a breast augmentation, and the patient should understand and document her acceptance of these conditions in informed consent documents. A surgeon’s willingness to adhere to stringent criteria for reoperations directly influences reoperation rates, risks, tradeoffs, and costs to the patient.

Unilateral versus Bilateral Implant Removal

When a condition requiring implant removal occurs unilaterally, removal of one implant creates a deformity (asymmetry) that virtually guarantees at least one reoperation to replace the implant. Unilateral implant removal encourages patients and surgeons to prioritize implant replacement, often sooner than is medically optimal. Unilateral implant removal can compromise future decisions and the timing of those decisions. When removal is indicated, bilateral implant removal totally avoids these compromises and eliminates a demand for reoperation based on asymmetry.

Implant Removal without Replacement: The Criteria

Every surgeon must define personal criteria for implant removal without replacement, based on clinical experience, medical indications, and logic. On the basis of more than two decades of experience, I recommend breast implant removal without replacement for the following clinical conditions or situations, and I require that every patient accept and acknowledge these criteria in informed consent documents before the primary augmentation

* Recurrence of capsular contracture after having performed a complete capsulectomy and implant replacement with a new (textured saline if the primary was silicone gel filled) implant for a first capsular contracture of grade III or IV (limits total reoperations for capsular contracture to two).

* Recurrence of stretch deformity (bottoming, lateral malposition) after having performed a previous capsulorrhaphy, partial capsulectomy (if indicated), and exchange to a smaller implant (limits total reoperations for stretch to two).

* Traction rippling or visible implant edges medially when there is no additional tissue coverage available locally (e.g., conversion of submammary to subpectoral), or when pectoralis coverage has been previously compromised by division of medial pectoralis origins.

* Culture-documented contamination or infection of the periprosthetic pocket, regardless of implant type or pocket location (any occurrence of documented infection). This approach optimizes rapid resolution and minimizes inflammatory effects on tissues that occur with prolonged salvage efforts, effects that may produce significant and sometimes uncorrectable tissue deformities over time. Further, this approach minimizes the risks and costs of future reoperations attempting reimplantation, and it eliminates reoperations for recurrent infection or capsular contracture that can occur after attempted reimplantation.

* Recurrent seroma, regardless of negative cultures, after treatment of an initial seroma with exploration, capsulectomy (if indicated), and prolonged drainage.

* Inadequate soft-tissue coverage, when pinch thickness of tissues covering any area of the implant is less than 0.5 cm (except when coverage deficit is medial or superior and can be improved by dual plane or retropectoral implant placement).

* In any situation where two previous reoperations have been performed, for any reason (limits reoperations to three, including removal without replacement).

Criteria to Limit Reoperations

The following criteria have evolved over more than two decades to limit reoperations with their inevitable risks, tradeoffs, and costs:

* No reoperations for implant size exchange if not medically necessary (e.g., a slightly larger implant after performing a capsulectomy, provided adequate soft-tissue coverage is available).

* No reoperations for grade II capsular contracture.

* No reoperations for minor stretch deformities [<3 cm of additional widening of the intermammary distance due to lateral envelope stretch, <2 cm of elongation of nipple-to-inframammary fold distance (bottoming) 6 months or more postoperatively regardless of emptying of upper breast or slight excess volume in lower breast].

* No reoperations to adjust nipple-areola position if sternal notch-to-nipple distances are within 1.5 cm bilaterally (for either primary or secondary procedures).

* No implant replacement if patient has previously required bilateral implant removal for any condition or suspected condition, including replacement of saline-filled implants following removal of silicone gel-filled implants to address concerns of connective tissue disease or other undefined symptom complexes or psychological conditions.

* No reoperations if patient is unwilling to sign detailed informed consent documents acknowledging that she understands and accepts that every reoperation involves additional risks, tradeoffs, and costs, that correction of any condition by reoperation is not guaranteed, and that with any reoperation, we may exchange one set of problems or compromises for a different and not necessarily better set of conditions.

Results

The above-described criteria, combined with implant selection based on quantifiable tissue characteristics and more detailed patient education and informed consent were applied in 1662 reported cases using textured, saline-filled breast implants with up to 7 years of follow-up. The resulting overall reoperation rate was 3 percent. Acknowledging the limitations of comparing the studies, this 3 percent overall reoperation rate at up to 7 years compares favorably to the overall reoperation rates of 13 and 21 percent at 3 years in the saline premarket approval studies of Mentor and McGhan and to the 20 percent reoperation rate at 2 years in the most recent silicone gel premarket approval submission by Inamed Corporation.

Discussion

Factors such as the surgeon’s experience, the surgeon’s technical skill, the reasons for reoperations (device-related versus surgery-related), and other factors preclude direct, scientifically valid comparisons between our reoperation rates and those of the premarket approval studies. Nevertheless, the large clinical experience with long-term follow-up reported in our studies includes every reoperation for any reason, similar to the premarket approval study results. In the premarket approval study, capsular contracture was categorized as a device-related reason for reoperation when in fact surgical tissue trauma and bleeding are significant if not major stimuli for capsular contracture. A reoperation is a reoperation, regardless of whether the patient requests it for size change or an improvement in aesthetics. Selective categorizing and analysis to shade interpretation of results and causes is largely nonproductive, if reducing reoperation rates is a goal. By defining and implementing out points and decision and management algorithms, we have dramatically reduced reoperation rates in our practice over the past two decades.

Conclusion

To reduce the rate of reoperations, with their inevitable risks, tradeoffs, and costs to patients, and to reduce the incidence of tissue-compromising deformities resulting from multiple reoperations, surgeons must define strict criteria for reoperations following breast augmentation and for bilateral implant removal without replacement. The criteria described in this article resulted in overall reoperation rates that are substantially lower compared with overall reoperation rates in recent large premarket approval submissions to the Food and Drug Administration. Each surgeon must define criteria according to his or her individual surgical experience and practice characteristics, but current Food and Drug Administration rulings and guidance suggest that continued availability of breast implant devices for patients demands that patients experience lower reoperation rates.

Dr Michele Koo feels very strongly that her patients can benefit from primary breast augmentation for elective cosmetic reasons as well as from breast implant revisions should the need arise. However, as the article above emphasizes, re-operation for breast implants have certain risks and complications that are out of the control of the surgeon and the patient. Dr Koo wants the best outcome for her patients and she feels that the better informed one is when going into the initial surgery, the easier it will be for all subsequent surgeries.

Dr Koo wants her patients to understand that no matter how pleased you may be with the original breast augmentation or revision surgery that once a breast implant is used, that will then obligate you to subsequent surgeries whether it is for an implant replacement after many years, or whether it is due to your breasts changing shape and size after children or weight gain and loss.

BEAUTIFUL BREAST REDUCTION - BREAST LIFT - DR MICHELE KOO - MISSOURI and ILLINOIS

Sunday, January 18th, 2009
BEFORE BREAST REDUCTION BY DR MICHELE KOO

BEFORE BREAST REDUCTION BY DR MICHELE KOO

AFTER BREAST REDUCTION BY DR KOO

AFTER BREAST REDUCTION BY DR KOO

 

 

 

 

 

 

 

 

DR MICHELE KOO, MD, FACS, BOARD CERTIFIED PLASTIC SURGEON

314-984-8331

ST LOUIS, MISSOURI, AND ILLINOIS

 

Did you know that breast reductions to relieve your back, neck and shoulder pain may be covered by your health insurance? DR MICHELE KOO, MD, FACS, BOARD CERTIFIED PLASTIC SURGEON, ST LOUIS, MISSOURI will let you know if she thinks that your breasts will qualify for insurance coverage when she examines you.

BREAST REDUCTIONS are extremely safe and can be performed on an outpatient basis under general anesthesia. There are no age limitations and DR MICHELE KOO will let you know if she feels that it is safe for you to undergo this procedure which takes approximately 1 1/2 hours to 2 1/2 hours.

While DR KOO feels that the surgery is a wonderful life enhancing surgery, she also wants you to know that there are limitations and complications that can occur with any surgery and BREAST REDUCTIONS are not exception. The BREAST REDUCTION surgery will lift your breasts, reshape your breasts, and lighten them to the point of allowing you to feel that you can exercise to improve your health and weight. DR KOO often says that the BREAST REDUCTION surgery will be one of the absolute best things that you have ever done for yourself. The surgery will relieve the sweaty skin rashes under your breasts, relieve the grooving in your shoulders from the weight of your breasts, help relieve the headaches, neck and back pain you suffer from your saggy heavy breasts.

According to Farzad and Foad Nahai, MDs, in the Plastic Surgery Journal on Breast Redutions in 2006, “there were 145,822 breast reductions performed in the United States, positioning breast reduction as the fifth most common plastic surgical procedure performed by plastic surgeons.  Breast reduction has one of the highest patient satisfaction rates among plastic surgery procedures, with 93 percent of women reporting they would undergo the surgery again.  Reduction mammaplasty has also been shown to improve body self-image.

There are many procedures available to accomplish breast reduction, each with its unique combination of skin incision and resection patterns and approach to breast reshaping. The inferior pedicle Wise pattern reduction mammaplasty has long been the favored procedure in the United States.  Lassus and Lejour were instrumental in popularizing the vertical pattern breast reduction in Europe, and this trend is now being adopted by North American surgeons as well.  

In-depth knowledge of breast anatomy-in particular, the blood and nerve supply to the nipple-areola complex-is prerequisite to any type of surgical procedure on the breast. Key sensory nerves are the lateral and medial cutaneous branches of the intercostal nerves T3, T4, and T5. The lateral branches exit the chest wall at the midaxillary line and progress medially along the pectoralis major fascia, with terminal sensory endings in the breast skin and the nipple-areola complex.  Branches from the lower cervical plexus supply sensation to the upper breast.

The blood supply to the breast is based on musculocutaneous perforators from the internal mammary, anterolateral intercostal and anteromedial intercostal, and fasciocutaneous perforators from the lateral mammary branches of the long thoracic artery. This network of vessels communicate with each other and branch and terminate at all four quadrants of the nipple-areola complex. In addition, the subdermal plexus is arranged in a radial pattern around the nipple-areola complex and provides for numerous pedicle options, including inferior, central, medial, superior, and lateral pedicles.  The viability of breast skin flaps is dependent on flap thickness, flap length-to-base width ratio, the presence of inflow vessels, and subdermal microcirculation. Factors such as smoking, radiation, and previous surgery can affect blood flow at these levels and result in breast flap necrosis. Cooper’s suspensory ligaments are the connective tissue support structures within the breast. These ligaments originate from the pectoralis muscle fascia and course through the breast parenchyma to attach to the dermis of the overlying skin. These attachments can be stretched with pregnancy, weight gain, and aging, resulting in excess breast mobility and ptosis.

In addition to the standard medical history and examination of pertinent systems, conditions that affect wound healing (such as smoking or diabetes) or bleeding times are of particular importance. Any history of easy bruising or extended bleeding times should be noted and a workup initiated when appropriate. Patients seeking breast reduction are often overweight, so any history regarding the risk of deep venous thrombosis or cardiopulmonary disease should be known. Any history of prior treatment for back pain, neck pain, or inframammary intertrigo should be documented, as most insurance companies will require this assessment before approving breast reduction. Familial or personal history of breast masses, breast cancer, abnormal mammograms, or current use of hormones (birth control pills or hormone replacement therapy) should be noted. History of pregnancy and breast feeding and maximum breast size during pregnancy and current bra size are recorded. Subjective report of nipple sensibility is also documented.

The physical examination includes patient height, weight, and calculation of the body mass index [weight in kilograms ÷ (height in meters)2]. A breast examination should be performed to asses the breasts for symmetry, the presence of masses, any evidence of shoulder notching from the bra, intertrigo, and the degree of breast ptosis. The description and grading of breast ptosis has been reported previously.  A set of objective breast measurements should be taken with a minimum measurement of the sternal notch to nipple distance and nipple to inframammary fold distance. Other helpful measurements are nipple-areola complex width, breast width, and nipple-to-sternal midline distances. Some authors include measurement of breast circumference and width to estimate breast weight.

Deep Venous Thrombosis/Pulmonary Embolism Prophylaxis

Women with a body mass index greater than 30 undergoing breast reduction have a low but real risk of deep venous thrombosis/pulmonary embolism.  Operative times greater than 2 hours can increase this risk. Established effective precautionary practice includes the use of pneumatic compression devices with or without thromboembolic disease hose. A recent meta-analysis has demonstrated a 60 percent decrease in the incidence of deep venous thrombosis/pulmonary embolism with the use of pneumatic compression devices.  To be fully effective, these devices should be on the patient and functioning before the induction of general anesthesia. The use of chemoprophylaxis administered subcutaneously in the perioperative period for plastic surgery procedures is currently controversial. There are no randomized clinical trials to evaluate the role of chemoprophylaxis in plastic surgery, and the risk of hematomas is unknown. Although the benefits and safety of chemoprophylaxis in general surgical and orthopedic procedures has been demonstrated, we cannot extrapolate the safety profile, in particular, the risk of hematoma, to plastic surgery procedures that involve a significant amount of undermining and raw surfaces. Current recommendations are that mechanical prophylaxis is used on any procedure lasting more than 1 hour and that chemoprophylaxis be used on major procedures such as abdominoplasty, thigh lift, belt lipectomy, transverse rectus abdominis myocutaneous flap reconstruction, surgical positions likely to contribute to venous stasis and/or compression, combined procedures, and procedures lasting more than 4 hours.

Smoking and Breast Reduction

Fortunately, smoking rates in the United States have been on the decline, attributable in part to comprehensive tobacco control programs. There is a direct link between smoking and delayed wound healing that represents a significant unfavorable shift in the risk-to-benefit ratio for breast reduction.

Many plastic surgeons insist that anyone who smokes more than the occasional cigarette must absolutely stop smoking at least 2 weeks before surgery. Patients can be referred to a smoking cessation program. A newer non-nicotine-containing medication, varenicline (Chantix; Pfizer, Inc., New York, N.Y.), has demonstrated some of the most effective smoking cessation rates among pharmacologic treatments. If necessary, serum nicotine levels can be checked before the procedure.

Informed Consent  

Informed consent includes a discussion of the location of surgical scars, the possibility that these scars can widen or thicken and that they are permanent. Temporary and permanent changes in nipple sensation, difficulty with breast-feeding or lactation, postoperative breast asymmetries, delayed wound healing, skin necrosis, partial or total nipple loss, hematoma, and seroma should be discussed. In addition to sharing preoperative and postoperative photographs of good results, it is beneficial to share photographs demonstrating some of the possible long-term complications and less favorable outcomes. Preoperative breast asymmetry is brought to the patient’s attention and the possibility of asymmetry postoperatively is discussed. A well-educated and well-informed patient with realistic expectations is more likely to tolerate a complication or less than ideal result than one who is not informed and ill prepared for the possibility of a suboptimal outcome. As Goldwyn said, the more the patient considers her reduction an aesthetic procedure, the less likely she is to be satisfied. The more she considers it a reconstructive procedure, the more likely she is to be satisfied. Breast reduction is a procedure covered by most insurance companies, provided that a minimum weight of tissue is removed. It can be challenging in some patients to estimate an accurate amount of tissue to be removed. These patients are informed of the possibility that their breast reduction may not meet certain insurance company criteria and thus the cost will not be covered.

Breast Reduction and Postoperative Lactation 

For women considering breast reduction that have yet to have children, the question of lactation following surgery should be addressed. Any significant resection of subareolar breast tissue will decrease the amount of breast tissue that is potentially milk producing. Several studies have demonstrated that approximately 70 percent of breast reduction patients can breast-feed but that only 30 percent do, similar to the rates in an unoperated population.  Although milk production may occur, lactation will be impossible following free nipple grafting.

Mammograms and Breast Cancer Surveillance 

Preoperative mammograms are obtained based on the recommendations made by the American Cancer Society. Women younger than 40 years with a family history of breast cancer or other risk factors and any woman older than 40 should have a mammogram before breast reduction to rule out the presence of abnormal findings. Women are informed that reduction mammaplasty will result in scarring and possible calcifications within the breast parenchyma that may be seen on future mammograms. For that reason, all women are advised to have a baseline mammogram 3 to 6 months after surgery that will serve as a baseline study with which to compare future studies.

The incidental finding of a cancer in breast reduction specimens is rare, less than 0.5 to 0.8 percent in large series.  A positive finding after surgery should be followed with a thorough workup, oncologic consultation, and treatment recommendations made based on findings. In the rare event that a suspicious mass is found during the breast reduction, an intraoperative frozen section can be performed to establish a diagnosis. Confirmation of a benign diagnosis does not require further action and the procedure can be completed as planned. If an equivocal or malignant diagnosis is made, the entire mass can be resected and the biopsy site marked (with clips or staples), and once an appropriate stopping point is reached, the breast can be closed and the case terminated. A formal workup should then take place with proper staging and oncologic consultation. This management strategy leaves most options available and involves the patient in the decision process. In some cases where the resection specimen contains the entire malignancy; radiation treatment according to a breast conservation therapy protocol may be the only adjuvant therapy necessary. Any formal oncologic procedure without proper staging, planning, and consent is not advised.

Choice of Location and Setting for Breast Reduction Surgery 

For the vast majority of patients, breast reductions are performed on an outpatient basis, either in a hospital, outpatient surgical center, or office-based surgicenter that has been accredited by the Association of Accrediting Ambulatory Surgical Facilities or state authorities. An office-based operating room that is not accredited is not the ideal setting and should be avoided. The patient’s general health, body mass index, and American Society of Anesthesiologists classification are taken into account when making the decision on an inpatient or outpatient procedure.

PROCEDURE OPTIONS IN BREAST REDUCTION 

There are many surgical options for breast reduction. Often the choice of surgical procedure is based on patient morphology, including body mass index and degree of nipple displacement, and the surgeon’s comfort level, training, and experience with certain procedures. Excellent results are produced with a variety of procedures; the key is to couple the patient’s needs and goals with a suitable operation. All procedures, except for liposuction only and reduction with free nipple graft, center on maintaining a vascular pedicle to the nipple-areola complex. There are four major steps in a reduction procedure: access incisions, parenchymal resection, breast shaping, and management of excess skin. Preinjection of the breast with epinephrine-containing solution should avoid the planned vascular pedicle to the nipple-areola complex. The safety and efficacy of epinephrine use and tumescent solution infiltration in reduction mammaplasty has been reported.  These methods decrease blood loss and decrease operative times. Although there is a theoretical increased risk of postoperative bleeding, this has not been proven.

The most common access incisions are the Wise and vertical patterns. The Wise pattern skin incision affords the widest access to the breast parenchyma and can accommodate a variety of pedicles. Making curvilinear incisions along the vertical and horizontal limbs instead of straight lines results in a more rounded final breast shape. Thinking in three dimensions, the cut edge of a sphere is not a straight line but a gentle curve. The vertical pattern skin incision affords adequate access to the breast parenchyma but to a lesser degree than the Wise incision. Multiple pedicle options are also possible. The circumareolar, Benelli type, access incision is limited by concentric skin excision around the nipple-areola complex. It offers more limited access to the parenchyma and limited pedicle choice to the nipple-areola complex.
There are a variety of patterns of parenchymal resection, and most can be undertaken through the skin incisions described above. With any type of resection, preservation of the pedicle to the nipple-areola complex is the priority. Breast shape is three dimensional, and the resection pattern should take into account the preservation and readjustment of this shape. Once the pedicle choice is made, the resection is undertaken with the final breast shape in mind. Typically, there is an incongruous amount of breast tissue laterally, which is usually addressed with direct resection and/or liposuction. Medial breast fullness is desirable, so tissue in this area is resected more conservatively, if at all. The same is true for upper breast fullness; tissue here is either preserved or, if resected, the breast reshaping fills the upper pole through transfer of new tissue to this area by means of reshaping technique.

The central mound technique of breast shaping is perhaps one of the easiest to visualize and execute, as it essentially mimics the shape of a round breast implant. The inferior pedicle Wise pattern shapes the breast by transposing the pedicle cephalad and supporting it with medial and lateral breast flaps.  The superior pedicle and superomedial pedicle techniques preserve upper breast tissue and use the medial and lateral breast pillars for projection, pedicle support, and eventual lower breast shape.  In the case of breast amputation and free nipple grafting (where a vascular pedicle to the nipple-areola complex is not a concern), Wise pattern lateral and medial breast flaps are closed around superocentrally preserved breast tissue. Ways of improving long-term results have been described, including an inferior breast mound to preserve the rounded appearance of the lower pole of the breast.  Whichever method of parenchymal resection is used, it is important to remember that it is not what is removed but what is left behind that counts.

In the final stage, excess skin is addressed. With the Wise pattern resection, excess skin is typically resected with the breast parenchyma. Final tailoring usually involves resection of medial and lateral dog-ears along the horizontal inframammary fold incision. If possible, final skin tailoring is performed in curvilinear fashion to mimic the curve on the cut end of a spherical object.  This maintains a rounded appearance and avoids a boxy flattened breast, especially in the inferior pole. With the vertical pattern incision, once the medial and lateral pillars are brought together, the excess vertical skin is tailor tacked to flatten the breast on lateral view, much like the inverted image of a naturally appearing breast. The excess skin at the base of the vertical component can be tailored for a purse-string closure, a mini-T closure, or a laterally extended L or J closure. The Benelli technique removes excess skin only in a concentric manner around the nipple-areola complex and relies on a purse-string closure to gather the wound edges around the nipple-areola complex. In larger resections, this can result in pleating, a starburst scar pattern, and flattening of the breast. The best results are achieved with a small resection. Another method of breast reduction is the no vertical scar technique originally described by Passot and more recently reported on by Lalonde et al. and Nagy et al. Its proponents claim that the elimination of the vertical scar improves safety and aesthetic results. 

Liposuction Alone

Liposuction-alone breast reduction is most effective in patients with mild volume excess, normal skin elasticity, and minimal ptosis. It is generally low impact and safe.  Liposuction alone is not a good choice in the young, more fibrous breast that has little fatty tissue. Furthermore, liposuction alone would not be covered by insurance.

Benelli Type Circumareolar Reduction 

This procedure accesses the breast parenchyma through a circumareolar incision. A central mound is preserved and surrounding breast tissue is removed. A donut skin excision is performed, and closure depends on a purse-string suture. This procedure is best for the mild to moderate reductions (approximately 200 g or less) with up to 3 cm of nipple-areola complex elevation needed. The circumareolar reduction has not gained wide acceptance in the United States because most reductions here are larger volumes. The purse-string closure can result in a flattened breast, pleating, and a starburst scar.

Wise Skin Pattern Reduction 

The Wise pattern skin excision and inferior dermoglandular pedicle represents the most popular breast reduction technique used by plastic surgeons in the United States. This skin pattern excision is very versatile and can accommodate an inferiorly, superiorly, or centrally based dermoglandular pedicle. It is applicable to a wide range of reductions, has a relatively easy learning curve, achieves predictable results, and has one of the safest and most reliable vascular pedicles to the nipple-areola complex, with a good record of maintaining nipple sensibility. Some of the disadvantages of this procedure are the lengthy scars, the need for significant flap undermining, and the risk of bottoming-out and pseudoptosis of the breast over time. A reliance on the skin to shape the breast rather than breast shaping through parenchymal sutures can result in flat, boxy, nonprojecting breasts.

Vertical Breast Reduction 

The vertical pattern breast reduction has been slowly gaining popularity in the United States. It has a circumareolar scar and a scar vertically down to the inframammary fold. It is particularly effective at preserving breast projection and shape. A vertical skin pattern may be combined with superior, medial, lateral, or inferior pedicles. This technique is effective for a wide range of reductions, reaching its limits as the inframammary fold to nipple-areola complex distance increases beyond 15 to 18 cm. In these patients, the redundant skin at the inframammary fold is less likely to be adequately managed with a purse-string suture alone, so a small T, L, or J excision of skin may be needed. This technique does have a long learning curve and does require some time postoperatively for tissue settling until the final breast shape is achieved.

Breast Amputation and Free Nipple Graft 

For extremely large (>2000 g) reductions and very ptotic breasts with very long nipple to notch distances, a reliable pedicle to the nipple-areola complex cannot always be preserved. In these patients, an amputation is performed based on the Wise skin pattern and the nipple is preserved and repositioned as a free graft on a deepithelialized bed. This is a safe and effective procedure for extremely large breasts and a less risky option for smokers. The nipple often undergoes desquamation in the course of healing, leading to partial pigment loss and loss of nipple projection. Pigment loss is more distressing and harder to manage in patients with black skin. This is very rare for DR MICHELE KOO, she usually is able to perform any amount of surgery up to 2800-3000 gms from each breast without a free nipple graft.

Preoperative Markings 

Markings should be made with the patient standing or sitting upright with the shoulders relaxed and slightly rolled back and face looking forward. There are many descriptions of particular marking techniques in breast reduction. Whatever the technique, there are several key principles common to all. Sternal midline and breast midlines are marked. The key marking that all other markings depend on is the new location of the nipple-areola complex. There are many methods and anatomical landmarks by which the new position of the nipple-areola complex can be based such as the anterior projection of the inframammary fold. Markings made with the breast weight partially supported (breast supported with the nonmarking hand) can aid in avoiding positioning the nipple-areola complex too high and keeping the horizontal incision within the inframammary fold. For the vertical technique, the nipple should be marked 1 to 2 cm lower than these standard markings. It is advisable to not fixate on a single measurement when deciding on the new position of the nipple-areola complex but rather to take into account the collective anatomical findings. These might include the patient’s height, new location of the nipple-areola complex relative to the humerus, and an imaginary line from the xiphoid to the anterior axillary fold, estimating the location of a low cut bra, shirt, or bathing suit line. Paying attention to these relationships avoids positioning the nipple-areola complex too high. The inframammary fold is marked, also with the breast supported to avoid placing this mark too low. If liposuction is to be performed as an adjunct, markings are made before surgery. Additional guidelines for markings that will enhance results are listed in. 

POST OPERATIVE MANAGEMENT 

Immediate Phase 

Breast incisions can be topped with adhesive tapes in the operating room. Liquid adhesives, such as benzoin or Mastisol (Ferndale Laboratories, Ferndale, Mich.), can prolong the adherence of tapes but may cause skin irritation and blistering. If drains are placed, they are typically removed on the first postoperative day, unless concomitant breast liposuction was performed, in which case the drains may be left in longer. Inpatients are monitored for nipple viability and hematoma by observing symmetry and firmness. All patients are given instructions to limit physical activity for 2 weeks or more. Activities of daily living are typically resumed on the first postoperative day. The first postoperative visit is at 1 week or earlier if needed. The tapes are exchanged and an examination confirms the state of the nipple, incisions, skin flaps, and overall breast symmetry.

Long-Term Postoperative Care 

Patients are given taping instructions for all incisions. In the absence of skin irritation, taping can be continued for 3 months to minimize scar appearance. A soft elastic nonwire support bra can be worn for the first 2 weeks and then weaned until the end of the fourth week, when the patient may wear their bra of choice. Follow-up should be arranged at 6 and 12 months to assess final breast shape, symmetry, and nipple-areola complex sensibility.

MANAGEMENT OF COMPLICATIONS 

Complications range from mild to severe and may be early or late. Total complication rates have been reported to range from 6 to 43 percent. The most common complication, independent of reduction technique, is delayed wound healing, which has been reported to be as low as 2.2 to 10 percent to as high as 20 to 30 percent.  Proper patient selection and surgical planning will help decrease the chances of certain undesirable outcomes. Gentle handling of tissues, being mindful of the dermoglandular neurovascular pedicle, maintenance of breast flaps of adequate thickness, and closure without undo tension are also important. Despite all this, in the best of hands and in the optimal patient, complications will occur. Fortunately, many of the complications that occur with reduction mammaplasty can be resolved with favorable outcomes.

Early Complications 

Delayed Wound Healing 

Delayed wound healing is the most common complication in reduction mammaplasty regardless of technique and is related to closure with undue tension, underlying pressure from a seroma or hematoma, flap necrosis and ischemia, infection, or background disease that delays wound healing (diabetes, poor nutrition, smoking, steroids).  Typical locations for wound dehiscence are the T-junction: the three-way intersection of the vertical and horizontal incisions, the purse-string closure of a vertical reduction, and the junction of the nipple-areola complex and vertical limb incision. Sometimes, delayed primary closure can be performed; however, these areas are often managed conservatively and left to close on their own once the underlying problem has been addressed.

Poor Nipple Vascularity 

Partial or total nipple necrosis can be a devastating complication. Early and frequent nipple monitoring with appropriate identification of a nipple with vascular compromise followed by appropriate action may avoid total nipple loss. Sometimes, the appearance of the nipple during inset is the initial sign that a problem may occur. A pale or bluish nipple with limited bleeding on the cut edge warrants very close postoperative observation. Poor or dark blue blood flow from a pin prick is also worrisome. Sometimes, the closure of all wounds, emergence from general anesthesia, patient rewarming, and a normal nonpharmacologic blood pressure will reverse the changes associated with poor vascularity to the nipple, and it will turn pink with normal capillary refill within the first hour after the end of general anesthesia. An objective assessment of the blood flow to the nipple is the fluorescein intravenous dye test and a Wood’s lamp.  If there is an indication of compromised vascularity, an immediate free nipple graft should be performed. A free nipple is grafted to healthy deepithelialized vascularized dermis. Grafting onto fat or a poorly vascularized area will not work. If the nipple shows signs of ischemia in the early postoperative period despite normal blood pressure and core body temperature, immediate action is taken. Provided that undue pressure on the nipple pedicle from a hematoma is ruled out, the nipple should be released from its inset position, effectively relieving undue tension on the nipple pedicle. The nipple will generally retract 1 or 2 cm. If the nipple does not show immediate signs of improved blood flow, the patient should be taken back to the operating room for conversion to a free nipple graft onto a well-vascularized bed. For cases where partial or total nipple necrosis was not identified or apparent in the early postoperative period, conservative wound care until closure is achieved by primary healing is best. Nipple reconstruction is then undertaken at an appropriate time. Depigmentation can be treated with tattooing, but results vary. Total nipple loss will require reconstruction with skin grafts and/or local flaps.

Hematoma 

Although not common, a hematoma may be hard to recognize until it is sizable. The presence of breast swelling, distensibility of the skin, and large areas of undermining can make a small hematoma hard to identify. Hematoma may occur within hours after surgery or up to 2 weeks postoperatively. Presentation of a hematoma can include unilateral pain, swelling beyond expectation with significant asymmetry, tight and discolored skin flaps, or excessive bloody output from a drain or suture line. Hematomas should be drained at the time of diagnosis in the operating room, with adequate lighting and access to hemostatic devices. Often, a definitive bleeding point is not found, but it should be pursued. Fluid resuscitation and blood administration are prescribed as indicated. Late hematomas should be aspirated with a large-bore needle or surgically drained to avoid abscess formation and contour deformities.

Skin Flap Necrosis 

Flap necrosis may be devastating and occurs when flaps are made too thin, the patient smokes (or is exposed to secondary smoke), or pressure necrosis occurs from dressings that are too tight or because of pressure from an underlying hematoma. As with the worrisome nipple, blood flow to suspect skin flaps can be measured objectively with intravenous fluorescein. If debridement and immediate direct closure without undo tension can be achieved, it is preferable. In more severe cases with large areas of tissue loss, conservative wound management with healing by secondary intention or early skin grafting is advised. Skin graft take on soft breast fat with poor circulation can be difficult to achieve. Hyperbaric oxygen therapy can accelerate healing but is costly.  A wound vacuum-assisted closure device may be considered in severe cases or in preparation for a skin graft.

Deep Venous Thrombosis/Pulmonary Embolism 

The most worrisome and life-threatening complication is deep venous thrombosis and/or pulmonary embolism. In the event of difficulty breathing or poor oxygen saturation within the first several days after surgery, deep venous thrombosis/pulmonary embolism is the assumed diagnosis until proven otherwise. The most rapid and minimally invasive method of diagnosis is a contrast-enhanced computed tomographic scan of the chest.  If contrast is contraindicated or a computed tomographic scan is unavailable, a ventilation/perfusion lung scan can be performed. A Doppler ultrasound examination of the lower extremities can also be performed looking for evidence of thrombosis. Management of deep venous thrombosis/pulmonary embolism has been described previously.

Infections 

Cellulitis can occur and may present as local erythema, increased pain or drainage, and/or fever. It should be treated immediately with the appropriate antibiotics and followed closely. Passage of a needle into the breast can rule out seroma or diagnose an underlying abscess. Abscess is rare, but should it occur, it should be drained.

Late Complications 

Seroma 

Untreated seromas can cause wound separation and delayed healing. If a seroma is suspected, it can be needle aspirated in the clinic. Often, multiple aspirations are required before the seroma resolves. Seromas recalcitrant to multiple aspirations can be excised directly and closed over drains with suturing to obliterate the dead space.

Scars 

Scars can be a problem because of poor location or hypertrophy/keloid formation. Simple taping is a very effective means of avoiding scar hypertrophy.  Should hypertrophy or keloids occur, treatment should start at the earliest indication. When they do occur, the vertical limb is usually spared. Direct lesional injections with steroids alone or in combination with 5-fluorouracil have been shown to be effective.  Scars above or below the inframammary fold can be distressing to the patient. Effort should be made to minimize medial extension of incisions on the breast, as the scar can be seen with low-cut clothing. With vertical scar reduction, the inframammary fold is often raised as a result of the reduction; thus, the vertical incision marking should end within 2 to 4 cm above the inframammary fold or the scar may extend below the inframammary fold. With circumareolar procedures, as the reduction volume increases, so does the risk of permanent skin pleating and starburst scar formation. These can be treated with conversion to a vertical or Wise scar pattern reduction for extra skin removal and formation of a new circumareolar skin-to-nipple-areola complex relationship that will avoid pleats and starburst scars.

Shape 

A problem shared by all breast reduction techniques is bottoming-out or pseudoptosis, defined as an excess amount of breast tissue extending below the inframammary fold with a normal nipple position. This is more often associated with the Wise pattern inferior pedicle reduction. Any effort to reshape a breast that has been previously reduced must take into account the pedicle to the nipple-areola complex and avoid its injury. Regardless of the access incisions, breast reshaping and skin tightening is used to recapture an acceptable breast shape. Small puckers, more common in vertical reductions, are excised directly, as are dog-ears that can occur with Wise pattern incisions.

Nipple Position 

Abnormal nipple position is very unforgiving and can mar the appearance of otherwise well-shaped symmetric breasts. Any effort to reposition a nipple must take into account the original pedicle to the nipple-areola complex and avoid vascular compromise. Minor nipple asymmetry can be managed with crescent skin removal from above the nipple. Nipples that need to be raised more than 1 cm must be released circumferentially and repositioned with the excess skin inferior retailored and incorporated into the vertical incision. Nipples that are too high are very problematic and difficult to manage. If there is concomitant bottoming-out of the breast, it is best to reshape the breast relative to the nipple. If the nipple is truly too high, it must be repositioned lower on the breast mound, leaving a scar above the nipple.

Asymmetry 

Minor asymmetry in shape or size is often acceptable to the patient, especially if the same asymmetric right-to-left relationship that was present preoperatively is maintained postoperatively. Significant size asymmetry can be managed with liposuction or further parenchymal resection.

Fat Necrosis 

Fat necrosis presents as a local area of firm or hard tissue. This is usually noted close to the breast surface, as it is more easily palpated there. Deeper areas of fat necrosis may be diagnosed only by radiography. Should fat necrosis occur, it should be needle aspirated to confirm the diagnosis and to rule out a neoplasm followed by excision or aspiration if symptomatic.

Changes in Nipple Sensation 

All patients are informed during the consent process that nipple sensation can permanently decrease, increase, or not change after reduction mammaplasty. Early changes in sensation are often temporary and should be managed expectantly until at least 6 months after surgery. Changes in nipple sensation have been documented up to 1 year after surgery. Multiple reports exist comparing techniques based on sensory outcomes. One demonstrated that no difference exists between medial and inferior dermoglandular pedicles and that resection weight was not a variable in sensory outcomes.  Another study did not find a difference between the techniques that preserved breast tissue at the base of the breast, but found that decreased sensation occurred with techniques that resected base of breast tissue.  No difference based on amount of breast tissue resected was found, confirming prior reports.

CONCLUSIONS 

With one of the highest satisfaction rates among plastic surgery procedures, breast reduction can be rewarding for both the patient and the physician. A clear understanding of breast anatomy is a prerequisite to performing any of the many techniques available. Common and critical to all techniques is the preservation of the vascularity to the nipple-areola complex. Currently, the most frequently used method for breast reduction is the Wise pattern inferior pedicle technique, although the vertical reduction method is gaining in popularity.

Excellent results can be achieved with many different types of procedures. Identification and proper early intervention of complications are important and integral to practicing safe and efficacious reduction mammaplasty.”

DR MICHELE KOO wants you to understand that still overall the BREAST REDUCTION procedure is one of the best things you will ever do for yourself, to enable yourself, and to break the cycle of large heavy breasts and the inability to exercise and then weight gain and further increase in breast size.

Take charge of your life now and call DR MICHELE KOO, MD, FACS. BOARD CERTIFIED PLASTIC SURGEON, ST LOUIS, MISSOURI for a BREAST REDUCTION consultation.  314-984-8331.

 

 

BREAST REDUCTION FOR NECK AND BACK PAIN RELIEF

Wednesday, September 24th, 2008

BREAST REDUCTION ST LOUIS-ILLINOIS-SPRINGFIELD

314-984-8331

DR MICHELE KOO, MD, FACS

BOARD CERTIFIED PLASTIC SURGEON

BEFORE BREAST REDUCTION 36 HH

BEFORE BREAST REDUCTION 36 HH

AFTER BREAST REDUCTION 38 C BRA

AFTER BREAST REDUCTION 38 C BRA

Have you always wanted shaplier, lifted, lighter perkier breasts?

Did you know that was possible and have your insurance cover the surgery?

Are you sick and tired of your skin sweating under your breasts and getting rashes all the time?

Are you tired of not being able to exercise and walk comfortably? Are you sick of the grooves in your shoulders?

The patient pictured in the photograph is a 36 year old woman from St Louis, Missouri who complained of skin rashes under her breasts, neck, shoulder, and back pain from her very heavy, pendulous breasts.

She underwent a breast reduction by DR MICHELE KOO, MD, BOARD CERTIFIED PLASTIC SURGEON, ST LOUIS, MISSOURI, 314-984-8331 and has been transformed from a 38 DDD/EE to a 36D.

She is ecstatic about her beautiful new breasts and has gained so much self confidence. Her friends keep asking her if she’s lost a great deal of weight. Her shoulders and neck no longer hurt and she is able to walk and exercise comfortably. She loves wearing pretty bras and cute tops and dresses.

She no longer has to spend a fortune on ugly big bras that look like parachutes.

Dr Michele D Koo, MD, FACS, Board Certified Plastic Surgeon, St Louis-Kansas City,Missouri and Illinois can reduce, lift, and reshape your breasts with a breast reduction (reduction mammaplasty) so that your back, neck, and shoulders are relieved of the grooving, pull, and pain.

The breast reduction surgery takes approximately 2 to 2 1/2 hours under general anesthesia and is extremely safe. You may either go home on the day of surgery or stay over night if you choose. You will drive the next day and you will be able to return to a office type of occupation in 1-3 days and in 7-14 days to a physical type occupation.

Your recovery time is minimal.

You will be given a surgical compressive bra after your breast reduction and may have some drains out the side of your breasts when you go home. Dr Koo will see you in the office 4 days after the surgery when the drains will likely be removed. Most patients rarely complain of pain after the surgery and are pleasantly surprised that the recovery is very minimal.

Dr Koo’s patients will tell you that the breast reduction surgery is one of the best things they have ever done for themselves.

The pre- breast reduction patients often feel so trapped by their heavy breasts. They feel they are unable to exercise adequately to loose weight and the more weight they gain the larger their breasts become. They are caught in a vicious cycle that they cannot break themselves.

Dr Koo sees patients from throughout Missouri, Cape Girardeau, Kansas City, Springfield, Farmington, Illinois and the remainder of the United States. Her office will make arrangements for your out of town stay and help you in any way you need.

Dr Michele Koo, MD, of St Louis, Missouri, 314-984-8331, can help you break that weight gain cycle and reduce, lift, and reshape your breasts.

You will have freedom like you’ve never had before and relief of shoulder, neck, and back pain. Your tension headaches should also lessen from the relief of the pull on your shoulders and neck.

You can feel like your breasts are youthful again, lifted, off of your tummy and back on your chest. The areola will be made smaller and shaplier and you will not have to deal with all of that excess breast tissue getting in your way.

Please feel free to call Dr Koo’s office, 314-984-8331, with questions and to talk to other patients who have undergone this exact surgery.

Begin your new life after breast reduction today, DR MICHELE D KOO, MD., 314-984-8331, ST LOUIS, MO.

 

 


back to the top